Senseonics Holdings, Inc. Schedules First Quarter 2021 Earnings Release & Conference Call for May 13, 2021 at 4:30 p.m. Easte...
April 29 2021 - 4:05PM
Business Wire
Senseonics Holdings, Inc. (NYSE-American: SENS), a medical
technology company focused on the development and commercialization
of long-term, implantable continuous glucose monitoring (CGM)
systems for people with diabetes, today announced that it plans to
release its first quarter 2021 financial results after market close
on Thursday, May 13, 2021.
Management will hold a conference call to review the company’s
first quarter 2021 performance starting at 4:30 p.m. (Eastern Time)
on the same day. The conference call will be concurrently webcast.
The link to the webcast will be available on Senseonics Holdings,
Inc. website at www.senseonics.com by navigating to “Investor
Relations,” and then “Events & Publications,” and will be
archived there for future reference. To listen to the conference
call, please dial 1-888-317-6003 (US/Canada) or 1-412-317-6061
(International), passcode 6107459, approximately ten to five
minutes prior to start time.
About Senseonics Senseonics Holdings, Inc. is a medical
technology company focused on the design, development and
commercialization of transformational glucose monitoring products
designed to help people with diabetes confidently live their lives
with ease. Senseonics' CGM Systems, Eversense® and Eversense® XL,
include a small sensor inserted completely under the skin that
communicates with a smart transmitter worn over the sensor. The
glucose data are automatically sent every 5 minutes to a mobile app
on the user's smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210429005796/en/
Senseonics Investor Contact Lynn Lewis or Philip Taylor
Investor Relations 415-937-5406 investors@senseonics.com
Senseonics (AMEX:SENS)
Historical Stock Chart
From May 2024 to Jun 2024
Senseonics (AMEX:SENS)
Historical Stock Chart
From Jun 2023 to Jun 2024